Quest Diagnostics Incorporated (DGX)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 1,262,000 1,130,000 1,180,000 1,220,000 1,428,000 1,829,000 2,089,000 2,234,000 2,381,000 2,640,000 2,706,000 2,456,000 1,971,000 1,539,000 1,134,000 1,158,000 1,231,000 1,088,000 1,079,000 1,077,000
Revenue (ttm) US$ in thousands 9,100,000 9,153,000 9,351,000 9,467,000 9,745,000 10,142,000 10,425,000 10,520,000 10,628,000 10,932,000 10,982,000 10,297,000 9,437,000 8,361,000 7,531,000 7,657,000 7,726,000 7,639,000 7,572,000 7,538,000
Operating profit margin 13.87% 12.35% 12.62% 12.89% 14.65% 18.03% 20.04% 21.24% 22.40% 24.15% 24.64% 23.85% 20.89% 18.41% 15.06% 15.12% 15.93% 14.24% 14.25% 14.29%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,262,000K ÷ $9,100,000K
= 13.87%

Quest Diagnostics, Inc.'s operating profit margin has displayed a fluctuating trend over the past eight quarters. The company's operating profit margin stood at 14.08% in Q4 2023, which was higher compared to the previous quarter but lower than the same period last year. The margin peaked at 20.90% in Q1 2022 and has since shown a downward trajectory, decreasing to 12.51% in Q2 2023. This suggests some variability in the company's ability to generate profits from its core operations. Further analysis into the underlying factors driving these changes would be necessary to understand the implications for the company's profitability and operational efficiency.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
Quest Diagnostics Incorporated
DGX
13.87%
Fulgent Genetics Inc
FLGT
-67.61%
Laboratory Corporation of America Holdings
LH
5.71%
RadNet Inc
RDNT
6.11%